Tumor Cells Exhibit Altered Glucose Metabolism Characteristics

Researchers in Berlin, Germany have published new data detailing the unique features of glucose metabolism in tumor cells. Unlike normal cells, which rely on oxygen to generate energy through the process known as cellular respiration, many tumor types exhibit impaired Pasteur effect, resulting in a high rate of glucose consumption even in the presence of oxygen, a phenomenon known as the Warburg effect. This altered metabolism allows tumor cells to thrive by rerouting glucose carbons to essential pathways required for survival under adverse conditions. The study provides a comprehensive review of the tumor-specific expression, activity, and kinetic properties of enzymes involved in glucose metabolism, shedding light on the regulatory basis and physiological significance of the Warburg effect.

Key Takeaways:

• The Warburg effect, a hallmark of cancer metabolism, involves the preferential consumption of glucose by tumor cells, even in the presence of oxygen.
• Tumor cells exhibit impaired Pasteur effect, resulting in an extraordinarily high rate of glucose consumption compared to normal tissue.
• Tumor cells acquire specific enzyme-regulatory mechanisms to redirect glucose carbons to essential pathways, enabling their survival under challenging conditions.
• The tumor-specific pattern of isozymes and metabolic regulation enables tumor cells to drain the blood glucose pool more quickly than non-transformed cells.
• A. Herling and colleagues conducted a comprehensive review of enzymes involved in glucose metabolism in tumor cells, highlighting their unique characteristics.
• The study's findings have implications for the understanding of cancer metabolism and the development of novel therapeutic strategies.

Statistics:

• 278 number of The Febs Journal (Enzymatic features of the glucose metabolism in tumor cells) volume and issue in which the study was published.
• 14 The issue number of The Febs Journal where the study was published.
• 2436-59 The page numbers where the study "Enzymatic features of the glucose metabolism in tumor cells" began and ended in The Febs Journal.
• USA The country where The Febs Journal publisher, Blackwell Publishing Inc., is located.

Sources:

• "Enzymatic features of the glucose metabolism in tumor cells." The Febs Journal, vol. 278, no. 14, 2011, pp. 2436-59.
• University Medicine Berlin (Charite), Institute of Biochemistry, Berlin, Germany.
• Blackwell Publishing Inc., 350 Main St., Malden, MA 02148, USA.
• Health & Medicine Week editors.